Opening Word document…
260 vaccines currently being developed now
PHRMA 22 [National Institute Health 4/?/2020 ; trade group representing companies in the pharmaceutical industry in the United States.; “New Era of Medicine: Vaccines,” https://www.phrma.org/science/new-era-of-medicine-vaccines]
As of April 2020, there are nearly 260 vaccines in development by America’s biopharmaceutical companies to both prevent and treat diseases including cancer, Alzheimer’s disease, allergies and autoimmune disorders. These vaccines offer significant hope for the future, with many vaccines in the pipeline using new technologies that have the potential to prevent the transmission of the human immunodeficiency virus (HIV), protect against malaria and even therapeutic vaccines to treat several types of cancer.
Sign in to recut, update, or save this card.